Literature DB >> 19881397

Aqueous vascular endothelial growth factor levels are associated with serous macular detachment secondary to branch retinal vein occlusion.

Sung Pyo Park1, Jae Kyoun Ahn, Gui Hyeong Mun.   

Abstract

PURPOSE: The purpose of this study was to determine whether aqueous levels of vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF) are associated with developments of serous retinal detachment (SRD) secondary to branch retinal vein occlusion.
METHODS: We recruited 102 patients with branch retinal vein occlusion and 10 controls. We divided patients into two groups according to optical coherence tomography images of the macula. Forty-six of 102 patients showed SRD defined as being subretinal fluid accumulation with low reflectivity, and the remaining 56 patients presented only cystoid macular edema (CME) defined as being hyporeflective intraretinal cavities. We measured the extent of vascular leakage (disk areas) by digital fluorescein angiography and evaluated the retinal ischemia defined as capillary nonperfusion. Aqueous concentrations of VEGF and pigment epithelium-derived factor were measured by enzyme-linked immunosorbent assay and compared between the two groups.
RESULTS: The incidence of major branch retinal vein occlusion was higher in the SRD group (38 of 46, 83%) than in the CME group (32 of 56, 66%, P = 0.01). The incidences of ischemic vein occlusion and macular ischemia was similar between the SRD group (18 of 46 and 20 of 46) and the CME group (20 of 56 and 24 of 56), whereas vascular leakage areas were larger in the SRD group than in the CME group (P = 0.02). Aqueous VEGF levels were higher in the SRD group than in the CME group (P < 0.001), whereas aqueous pigment epithelium-derived factor levels were similar. Vascular endothelial growth factor levels were positively correlated with pigment epithelium-derived factor levels (P < 0.001).
CONCLUSION: Our results indicate that excessive increase in vascular permeability because of VEGF upregulation may contribute to the development of SRD secondary to branch retinal vein occlusion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19881397     DOI: 10.1097/IAE.0b013e3181b9f153

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  14 in total

1.  OCT patterns of macular edema and response to bevacizumab therapy in retinal vein occlusion.

Authors:  Alexandra Eva Hoeh; Mira Ruppenstein; Thomas Ach; Stefan Dithmar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-02       Impact factor: 3.117

2.  Intravitreal dexamethasone implant with retinal photocoagulation for adult-onset Coats' disease.

Authors:  Kshitiz Kumar; Pallavi Raj; Nisha Chandnani; Amar Agarwal
Journal:  Int Ophthalmol       Date:  2018-01-29       Impact factor: 2.031

3.  Validation of molecular and genomic biomarkers of retinal drug efficacy: use of ocular fluid sampling to evaluate VEGF.

Authors:  Rajesh K Sharma; Cheryl L Rowe-Rendleman
Journal:  Neurochem Res       Date:  2010-12-07       Impact factor: 3.996

4.  Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion.

Authors:  J Moon; M Kim; M Sagong
Journal:  Eye (Lond)       Date:  2016-05-27       Impact factor: 3.775

5.  Visual prognosis and vitreous molecules after vitrectomy for macular edema with branch retinal vein occlusion.

Authors:  Hidetaka Noma; Hideharu Funatsu; Tatsuya Mimura; Shuichiro Eguchi; Katsunori Shimada
Journal:  Clin Ophthalmol       Date:  2011-02-15

6.  Combined intravitreal bevacizumab with phacoemulsification in visually significant cataract and visually significant exudative maculopathy.

Authors:  Ahmad Mansour; Ziad F Bashshur; Tarek A Sibai; Abla Mehio-Sibai; Rola N Hamam
Journal:  Oman J Ophthalmol       Date:  2011-01

7.  Vitreous inflammatory factors and serous retinal detachment in central retinal vein occlusion: a case control series.

Authors:  Hidetaka Noma; Hideharu Funatsu; Tatsuya Mimura; Shuichiro Eguchi
Journal:  J Inflamm (Lond)       Date:  2011-12-12       Impact factor: 4.981

8.  Visual function and serous retinal detachment in patients with branch retinal vein occlusion and macular edema: a case series.

Authors:  Hidetaka Noma; Hideharu Funatsu; Tatsuya Mimura; Katsunori Shimada
Journal:  BMC Ophthalmol       Date:  2011-09-26       Impact factor: 2.209

9.  Investigation of retinal morphology alterations using spectral domain optical coherence tomography in a mouse model of retinal branch and central retinal vein occlusion.

Authors:  Andreas Ebneter; Cavit Agca; Chantal Dysli; Martin S Zinkernagel
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

10.  Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion.

Authors:  Taiichi Hikichi; Makoto Higuchi; Takuro Matsushita; Shoko Kosaka; Reiko Matsushita; Kimitaka Takami; Hideo Ohtsuka; Hirokuni Kitamei; Shoko Shioya
Journal:  Br J Ophthalmol       Date:  2013-11-08       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.